葡萄叶绿体rbcL基因的结构分析

以玫瑰香葡萄（Ｖｉｔｉｓｖｉｎｉｆｅｒａ Ｌ．）为材料,克隆了含有叶绿体ｒｂｃ Ｌ基因的３．１ ｋｂ Ｂａｍ ＨⅠ片段,构建了该基因的限制性酶切图谱,测定了该基因的核苷酸序列。所测的核苷酸序列总长度为２００４ ｂｐ,其中基因的编码区为１４２８ ｂｐ,编码一个含４７５ 个氨基酸的蛋白质,其分子量约为５３ ｋＤ;测定基因的５上游含启动子的部分共３５８ ｂｐ,包括－ １０ 区（ＴＡＡＡＡＴ）、－ ３５区（ＴＴＧＣＧＣ）和ＳＤ 序列（ＧＧＡＧＧ）;基因的３下游区共２１８ ｂｐ,含有３ 个转录茎环终止结构。玫瑰香葡萄ｒｂｃ Ｌ基因编码区的核苷酸序列与烟草、矮牵牛、菠菜、苜蓿、水稻和玉米之间的同源性分别为９１．５％ 、９１．４％ 、９０．２％ 、８９．８％ 、８６．３％ 和８４．５％ ;推导出的氨基酸序列的同源性分别为９２．２％ 、９１．６％ 、９２．２％ 、９３．７％ 、９３．５％ 和９０．１％ 。     

陕西省常见蜜源植物花粉形态的研究

运用扫描电子显微镜,对陕西省境内３０种常见蜜源植物的花粉粒进行了观察研究,描述了花粉粒的大小、萌发孔类型及其表面纹饰等形态特征。结果表明：绝大多数种的蜜源植物,其花粉粒的形态特征明显不同。本文还就花粉粒形态特征,在鉴定蜜源植物花粉的属种,确定蜂蜜的产地、评价蜂蜜的品质等方面进行了探讨。     

Zn对细胞保护作用机理的研究

应用扫描质子微探针和同步辐射ｘ荧光分析技术测定了细胞中元素的分布和组成,为确定Zn是细胞结构成分提供了直接的实验依据.用上述核技术结合有关生化指标,分析测定了正常和损伤细胞（脂质过氧化损伤）中Fe,Zn和丙二醛、SH基含量变化的相互关系.实验结果表明,当细胞发生脂质过氧化损伤时,Fe含量和丙二醛含量同步增高,而Zn含量和SH基量则降低.给细胞补充Zn后,提高了细胞质膜中的Zn含量,SH基量也随之增加,同时丙二醛量降低.提示Zn保护细胞完整性的作用机理之一是控制脂质过氧化作用.Zn可保护膜蛋白的SH基,减少和阻止被Fe所催化的过氧化反应.     

江西忍冬属药用植物资源

报道了江西忍冬属药用植物种类、地理分布、临床疗效、化学成分等有关情况,对该属资源的开发利用提出了合理建议。     

γ射线诱发大鼠胚胎细胞转化与N－ras的激活

以γ射线诱发转化的大鼠胚胎细胞(REC:myc:γ33)的DNA构建粘粒基因库,用总基因库DNA转染NIH/3T3细胞,产生转化灶的DNA作二轮转染,二轮转化的NIH/3T3细胞内有大鼠REC:myc:γ33DNA中具转化活性的N-ras基因,用不对称PCR和DNA序列分析法证明,REC:myc:γ33细胞中鼠N-ras的活化是由于第61位密码子的A→G点突变.NIH/3T3转化灶中鼠N-ras也有同样点突变,但NIH/3T3细胞的内源性N-ras基因则无此突变.     

沈阳西部污灌水中有机污染物的分析

沈阳西部污灌水中有机污染物的分析刘海玲,张丽珊,姚家彪,于殿臣,朱岩,可夫,姜萍（中国科学院沈阳应用生态研究所,１１００１５）ＡｎａｌｙｓｉｓｏｆＯｒｇａｎｉｃＰｏｌｌｕｔａｎｔｓｉｎＩｒｒｉｇａｔｅｄｓｅｗａｇｅＩｎＷｅｓｔｅｒｎＳｈｅｎｙａｎｇ．...     

HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis

We investigated the polymorphic second exon of the HLA-DPB1 and HLA-DRB1 genes, using in vitro DNA amplification by polymerase chain reaction (PCR) and oligonucleotide hybridization in 136 patients with early onset pauciarticular juvenile chronic arthritis (EOPA-JCA) and 199 healthy controls. The analysis of the HLA-DRB1 system revealed that most of the DRB1 alleles are not indifferent with respect to susceptibility to EOPA-JCA. There is a hierarchy of susceptible (DRB1*08, DR5), permissive (DRB1*01), moderately protective (DR2, DRB1*04), and protective (DRB1*07) alleles. In contrast, no hierarchy could be shown for the HLA-DPB1 system. DPB1*0201 was found to be susceptible. The relatively frequent alleles DPB1*0402 and DPB1*0401 seem to be indifferent. The associations with DPB1*0201, DR5, and DRB1*08 are independent of each other: that is to say they, are not brought about by linkage disequilibrium. The susceptible alleles DPB1*0201 and DR5 show evidence for interaction in the pathogenesis of EOPA-JCA. Interaction seems likely between DPB1*0201 and DRB1*08, DR5 and DRB1*08, or between DR6 and DRB1*08. The strongest interaction exists between DPB1*0201 and a common DQ factor associated with both DR5 and DRB1*08. Finally, we observed a hierarchy among the various marker combinations, where the risk of developing EOPA-JCA increases with the number of associated markers present in an individual.This work was supported by SFB217.The data presented here are part of the doctoral thesis of C. Paul.     

Polymorphism of the DQA1 promoter region (QAP) and DRB1, QAP,DQA1, DQB1 haplotypes in systemic lupus erythematosus

We have investigated the DNA polymorphism for the DQA1 promoter region (QAP) and HLA-class II DRB1, DQA1, and DQB1 genes in 178 central European patients with Systemic lupus erythematosus (SLE) using polymerase chain reaction and Dig-ddUTP labeled oligonucleotides. Increased frequencies of DRB1*02 and *03 are confirmed by DNA typing. In addition, the frequencies of DQA1*0501, *0102 and DQB1*0201, *0602 alleles are increased in the patients as compared to controls. The strongest association to SLE is found with DRB1*03 and DQB1*0201 alleles (p<10^–7, p corr. <10^–5 and p<10^–6, p corr. <10^–4, respectively). By investigating the DQA1 promoter region in the SLE patients we have detected nine different QAP variants. Increased frequencies of QAP1.2 and QAP4.1 are observed in patients as compared to controls (p <0.05, p corr. = n. s.). Analysis of linkage disquilibria demonstrates a very strong association between QAP variants and DQA1, DRB1 alleles. Certain QAP variants are completely associated with DQA1 and DRB1 alleles, whereas others can combine with different DQA1 and DRB1 alleles. All DRB1*02-positive patients and controls carry QAP1.2, and all DRB1*03-positive patients and controls carry QAP4.1. Conversely, the QAP1.2 variant appears only in DRB1*02 haplotypes, while the QAP4.1 variant can be observed in DRB1*03, *11, and *1303 haplotypes. Based on the strong linkage disequilibria between DRB1-DQA1-DQB1 genes and between DRB1-QAP-DQA1, we have deduced the four-point haplotypes for DRB1-QAP-DQA1-DQB1 in patients and controls. Two haplotypes DRB1*02-QAP1.2-DQA1*0102-DQB1*0602-and DRB1*03-QAP4.1-DQA1*0501-DQB1*0201 are significantly increased in patient as compared to controls (p<0.01, p corr. = n.s., RR = 1.8 and p <10^–7, p corr. <10^–5, RR = 3.1, respectively). The analysis of relative risks attributed to the various alleles of QAP, DQA1, and DQB1 as well as the investigation of the deduced DRB1-QAP-DQA1-DQB1 haplotypes leads to the conclusion that QAP4.1 and DQA1*0501 on the DR3 haplotypes are probably not involved in SLE susceptibility. There is no evidence for the involvement of DQ2 / dimers coded in transposition. Thus, susceptibility to SLE is on the DR3 haplotype most probably localized at DRB1 or telomeric of DRB1, while for the DR2 haplotype such orientation cannot be given. SLE study group members: M. Baur, A. Corvetta, H. Ehrfeld, J. Frey, J. R. Kalden, F. Krapf, B. Lang, G. G. Lange, K. Pirner, C. Rittner, E. Röther, P. Schneider, H. P. Seelig, S. Seuchter, W. Stangel, C. Specker, P. Späth, H. Deicher. Correspondence to: Z. Yao.